Premium
PPIs and hypomagnesaemia: more common than we thought?
Author(s) -
Thompson Angus
Publication year - 2017
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1565
Subject(s) - medicine , adverse effect , side effect (computer science) , intensive care medicine , audit , pediatrics , management , computer science , economics , programming language
Proton pump inhibitors (PPIs) are associated with several well‐documented side‐effects but one emerging adverse effect, hypomagnesaemia, has so far tended to slip under the radar. In a small audit, the author investigated the rates of magnesium supplementation among PPI users, as a potential indicator of hypomagnesaemia. The results suggest this side‐effect could be more common than previously thought.